SGF® (Dental Pulp Stem Cell Culture Supernatant) is manufactured at the cultivation facilities of Ginza Solaria Clinic and Solaria Clinic Group subsidiaries (CPC).

As SGF® does not fall under the category of “Specific Cell Processed Products,” there is no requirement for procedures under the “Act on the Safety of Regenerative Medicine, etc.” However, to ensure the safety of production, our clinic’s laboratory is registered as a “Cell Cultivation Processing Facility” for manufacturing “Specific Cell Processed Products.”

Ginza Solaria Clinic: FC3200112

Cultivation Facility (CPC) Owned by Solaria Clinic Group Subsidiaries: FC3190004

Also, within the laboratory, individuals holding the certification of Clinical Cultivationist accredited by the Japan Society for Regenerative Medicine are involved in the production of SGF®.

※「The structural facilities of the cell culture processing facility must conform to the standards set forth by the Ministry of Health, Labour and Welfare ordinance. (Article 42 of the Act on Securing Safety of Regenerative Medicine, etc.)」